Summary
Forest Laboratories, Inc. (Forest Lab) is a pharmaceutical company focused on identifying, developing, manufacturing and marketing of pharmaceutical products including ethical and over the counter drugs in branded and generic forms. Forest Lab owns franchisees in the areas of cardiovascular, central nervous systems and others. The company is present in therapeutic areas including cardiovascular, central nervous system, endocrinology, pain management and respiratory. It also specializes in the development and launch of new products, including products developed in partnership with other companies. Forest Lab’s key prescription products include Lexapro, Namenda, Campral, Savella and Bystolic. The company operates in the US, Canada, Ireland and the UK. Its products are sold directly to physicians, pharmacies, hospitals, managed care and other healthcare organizations. Forest Laboratories is headquartered in New York, the US.
Forest Laboratories, Inc. (FRX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Forest Laboratories, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Forest Laboratories, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 7
Forest Laboratories, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Forest Laboratories, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 9
Forest Laboratories, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Forest Laboratories, Inc., Medical Equipment, Deal Details 11
Partnerships 11
Acton Pharma Enters Into Licensing Agreement With Forest Labs 11
Activaero Enters Into Collaboration With Forest Healthcare 12
Lupin Enters Into An Agreement With Forest Labs 13
Debt Offering 14
Forest Lab Completes Private Placement Of Notes Due 2019 For US$1.05 Billion 14
Forest Lab Completes Private Placement Of Notes Due 2021 For US$750 Million 15
Forest Labs Completes Private Placement Of Notes Due 2021 For US$1.2 Billion 16
Acquisition 17
Actavis Completes Acquisition of Forest Labs for USD28 Billion 17
Forest Lab Completes Acquisition Of Aptalis Pharma From TPG Capital For US$2.9 Billion 20
Forest Labs Completes Acquisition Of Clinical Data 22
Forest Laboratories, Inc. - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Financial Announcements 29
Apr 29, 2014: Forest Laboratories Reports Fiscal Year Fourth Quarter 2014 29
Jan 21, 2014: Forest Laboratories Reports Fiscal Year Third Quarter 2014 32
Jan 02, 2014: Forest Laboratories Sets Date and Conference Call for Fiscal 2014 Third Quarter Earnings 34
Jan 02, 2014: Forest Laboratories Sets Date and Conference Call for Fiscal 2014 Third Quarter Earnings 35
Oct 22, 2013: Forest Laboratories Reports Fiscal Year Second Quarter 2014 Diluted Earnings Per Share of $0.26 Including Effect of $0.10 Per Share of Acquisition Amortization 36
Oct 01, 2013: Forest Laboratories Sets Date and Conference Call for Fiscal 2014 Second Quarter Earnings 38
Jul 23, 2013: Forest Laboratories Reports Fiscal Year First Quarter 2014 Diluted Earnings Per Share of $0.09 Including Effect of $0.09 Per Share of Acquisition Amortization 39
Jul 01, 2013: Forest Laboratories Sets Date and Conference Call for Fiscal 2014 First Quarter Earnings 41
Apr 23, 2013: Forest Labs Reports Revenue Of $3.1 Billion In Fiscal 2013 42
Jan 15, 2013: Forest Labs Reports Revenue Of $722.7m In Q3 Fiscal 2013 44
Corporate Communications 46
Jul 08, 2014: Forest Laboratories To Lay Off 190 Employees At Earth City Facilities 46
Jan 10, 2014: Forest Laboratories Names Karen L. Ling Senior Vice President, Chief Human Resources Officer 47
Dec 09, 2013: Forest Laboratories Announces Appointments to its Executive Team 48
Nov 11, 2013: Forest Laboratories Names A. Robert D. Bailey Senior Vice President, Chief Legal Officer and General Counsel 49
Oct 25, 2013: Forest Laboratories names Alex Kelly Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations 50
Sep 10, 2013: Forest Laboratories Names Brent Saunders CEO and President 51
May 23, 2013: Forest Labs CEO Howard Solomon To Retire 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
List Of Tables
List of Tables
Forest Laboratories, Inc., Medical Equipment, Key Facts 1
Forest Laboratories, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Forest Laboratories, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Forest Laboratories, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 7
Forest Laboratories, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Forest Laboratories, Inc., Deals By Market, 2008 to YTD 2014 9
Forest Laboratories, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Acton Pharma Enters Into Licensing Agreement With Forest Labs 11
Activaero Enters Into Collaboration With Forest Healthcare 12
Lupin Enters Into An Agreement With Forest Labs 13
Forest Lab Completes Private Placement Of Notes Due 2019 For US$1.05 Billion 14
Forest Lab Completes Private Placement Of Notes Due 2021 For US$750 Million 15
Forest Labs Completes Private Placement Of Notes Due 2021 For US$1.2 Billion 16
Actavis Completes Acquisition of Forest Labs for USD28 Billion 17
Forest Lab Completes Acquisition Of Aptalis Pharma From TPG Capital For US$2.9 Billion 20
Forest Labs Completes Acquisition Of Clinical Data 22
Forest Laboratories, Inc., Key Competitors 25
Forest Laboratories, Inc., Key Employees 26
Forest Laboratories, Inc., Other Locations 27
Forest Laboratories, Inc., Subsidiaries 27
List Of Figures
List of Figures
Forest Laboratories, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Forest Laboratories, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Forest Laboratories, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Forest Laboratories, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Forest Laboratories, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Forest Laboratories, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 7
Forest Laboratories, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Forest Laboratories, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 9
